- Home
- DCTH vs NAK Comparison
DCTH vs NAK Comparison
Compare DCTH & NAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCTH
- NAK
- Stock Information
- Founded
- DCTH 1988
- NAK 1983
- Country
- DCTH United States
- NAK Canada
- Employees
- DCTH N/A
- NAK 12
- Industry
- DCTH Medical/Dental Instruments
- NAK Precious Metals
- Sector
- DCTH Health Care
- NAK Basic Materials
- Exchange
- DCTH Nasdaq
- NAK Nasdaq
- Market Cap
- DCTH 388.3M
- NAK 452.4M
- IPO Year
- DCTH N/A
- NAK 2002
- Fundamental
- Price
- DCTH $11.75
- NAK $0.82
- Analyst Decision
- DCTH Strong Buy
- NAK Strong Buy
- Analyst Count
- DCTH 4
- NAK 1
- Target Price
- DCTH $24.50
- NAK $2.50
- AVG Volume (30 Days)
- DCTH 497.8K
- NAK 3.4M
- Earning Date
- DCTH 11-07-2025
- NAK 11-14-2025
- Dividend Yield
- DCTH N/A
- NAK N/A
- EPS Growth
- DCTH N/A
- NAK N/A
- EPS
- DCTH 0.06
- NAK N/A
- Revenue
- DCTH $70,240,000.00
- NAK N/A
- Revenue This Year
- DCTH $159.22
- NAK N/A
- Revenue Next Year
- DCTH $42.78
- NAK N/A
- P/E Ratio
- DCTH $211.26
- NAK N/A
- Revenue Growth
- DCTH 491.35
- NAK N/A
- 52 Week Low
- DCTH $8.08
- NAK $0.30
- 52 Week High
- DCTH $18.23
- NAK $2.40
- Technical
- Relative Strength Index (RSI)
- DCTH 59.13
- NAK 41.79
- Support Level
- DCTH $10.61
- NAK $0.79
- Resistance Level
- DCTH $11.38
- NAK $0.94
- Average True Range (ATR)
- DCTH 0.49
- NAK 0.03
- MACD
- DCTH 0.06
- NAK 0.01
- Stochastic Oscillator
- DCTH 79.61
- NAK 24.00
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
About NAK Northern Dynasty Minerals Ltd.
Northern Dynasty Minerals Ltd is a mineral exploration company. It has a single operating segment of acquisition, exploration, and development of mineral properties. Its core asset is the Pebble Project located in Alaska, USA. The Pebble project is seeking to develop a deposit of copper, gold, molybdenum, and silver into a modern mining operation.